Boards & Committees - Corporate Development




COMMITTEE COMPOSITION

  • The Corporate Development Committee shall consist of a Chair (the Secretary-Treasurer of the Society) and four members appointed by the Board for 2-year staggered terms, renewable twice.
  • One member shall represent heart, one shall represent lung, one shall represent MCS, and one shall represent PH.
  • The President, President-Elect, and Executive Director shall also serve as members of the Corporate Development Committee.


COMMITTEE RESPONSIBILITIES

  • Work with the Board and Scientific Councils to identify strategic opportunities related to industry partnerships.
  • Work with the Executive Director to develop the Society’s annual corporate partner opportunities.
  • Meet with company representatives to discuss ISHLT’s programs and activities and potential areas for collaboration with companies.
  • Serve as the responsible entity for negotiating corporate support partnerships.
  • Seek assistance, as needed, from the Scientific Council Operating Boards to establish relationships with companies and to negotiate support agreements.
CORPORATE DEVELOPMENT COMMITTEE


COMMITTEE CHAIR
ISHLT SECRETARY/TREASURER
Joseph Rogers, MD
Duke University Medical Center
Durham, NC, USA
314-454-2694
joseph.rogers@duke.edu
ISHLT PRESIDENT
Maryl R. Johnson, MD
University of Wisconsin
Madison, WI, USA
608-263-0080
mrj@medicine.wisc.edu
ISHLT PRESIDENT-ELECT
Andrew J. Fisher, FRCP, PhD
Freeman Hospital
Newcastle Upon Tyne, UK
44-191-233-6161
a.j.fisher@ncl.ac.uk
EXECUTIVE DIRECTOR
Amanda Rowe
ISHLT
14673 Midway Rd., Suite 200
Addison, Texas, 75001
972-490-9495
amanda.rowe@ishlt.org



Text SizeIncrease Font SizeDecrease Font Size